After participating in this educational activity, attendees should be able to:

1. Discuss pharmacologic agents currently being used in practice
2. Review GLP-1 receptor agonists with a focus on semaglutide
3. Understand key concepts from the STEP 1 trial
4. Determine appropriate therapy given a patient case

Faculty

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.